Hikma Gets FTC Nod For Custopharm Deal – But With Strings Attached
Acquisition Moves Closer To Completion, But Combining Firms Must Lose A Product
• By David Wallace
The FTC has required the transfer of one Custopharm product • Source: Andriy Blokhin / Alamy Stock Photo 
